Virax Biolabs Group Limited (NASDAQ:VRAX) Financings

Virax Biolabs Group Limited

Financings

RaiseDate
Ordinary shares on exercise of preferred investment options
Closed: US$3.3M in the latest tranche · US$6 a share · Warrants at US$6 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital for general corporate purposes
Jul 16, 2026
Private placement of ordinary shares (or pre-funded warrants) and preferred investment options
Closed: US$5M raised · US$0.3999 a share · Warrants at US$0.4 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: General working capital, extending cash runway into the first half of 2028
Dec 4, 2025

Read by 6ix AI from the company's releases